2:1 ketogenic diet and low-glycemic-index diet for the treatment of chronic and episodic migraine: a single-center real-life retrospective study.
Headache
Ketogenic diet
Low-glycemic index diet
Migraine
Migraine prophylaxis
Journal
The journal of headache and pain
ISSN: 1129-2377
Titre abrégé: J Headache Pain
Pays: England
ID NLM: 100940562
Informations de publication
Date de publication:
28 Jul 2023
28 Jul 2023
Historique:
received:
24
05
2023
accepted:
19
07
2023
medline:
31
7
2023
pubmed:
28
7
2023
entrez:
27
7
2023
Statut:
epublish
Résumé
The evidence supporting the efficacy of dietary preventive therapy in migraine is rising, particularly regarding the ketogenic diet. However, less evidence exists for the Low-Glycemic Index Diet and the 2:1 KD. This retrospective single-center real-life study aims to evaluate the efficacy of a 2:1 ketogenic diet and a Low-Glycemic-index Diet in chronic and high-frequency episodic migraine. Sixty patients with high-frequency episodic and chronic migraine were treated with either a Low-Glycemic-index diet (39 patients) or a 2:1 (21 patients) ketogenic diet for three months. We collected data on the migraine frequency and intensity and the MIDAS and HIT-6 scores through the headache diary. Anthropometric measurements (BMI, fat mass, free fat mass, and weight) were also collected and analyzed similarly. Data obtained at the baseline and after three months of each diet were compared. Migraine intensity, frequency, MIDAS and HIT-6 scores, fat mass, weight, and BMI improved in both diet groups. Both diets are effective in reducing migraine symptoms and migraine-related disability.
Identifiants
pubmed: 37501109
doi: 10.1186/s10194-023-01635-9
pii: 10.1186/s10194-023-01635-9
pmc: PMC10375678
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
95Informations de copyright
© 2023. The Author(s).
Références
Br J Nutr. 2022 Oct 28;128(8):1535-1544
pubmed: 34763733
Headache. 2017 Nov;57(10):1532-1544
pubmed: 28984356
J Headache Pain. 2016;17:58
pubmed: 27245682
Eur J Neurol. 2023 Jan;30(1):224-234
pubmed: 36097739
Headache. 2013 Sep;53(8):1278-99
pubmed: 23808666
Cephalalgia. 2010 Aug;30(8):1014-6
pubmed: 20656714
Front Neurol. 2018 Feb 12;9:64
pubmed: 29483892
Nutrients. 2021 Jul 05;13(7):
pubmed: 34371817
Neurotherapeutics. 2018 Apr;15(2):336-345
pubmed: 29616493
Nutrients. 2020 May 28;12(6):
pubmed: 32481555
Neurol Sci. 2021 Sep;42(9):3865-3870
pubmed: 33527209
J Clin Med. 2022 Aug 23;11(17):
pubmed: 36078876
Neurol Sci. 2017 May;38(Suppl 1):111-115
pubmed: 28527061
BMC Neurol. 2019 Jun 22;19(1):136
pubmed: 31228957
Neurol Clin. 2019 Nov;37(4):631-649
pubmed: 31563224
Nutrients. 2019 Jul 29;11(8):
pubmed: 31362440
J Neurosci Rural Pract. 2019 Jul;10(3):552-554
pubmed: 31595134
Clin Neurol Neurosurg. 2020 May;192:105727
pubmed: 32087500
Nutr Metab Cardiovasc Dis. 2015 Apr;25(4):370-5
pubmed: 25698152
Eur J Neurol. 2015 Jan;22(1):170-7
pubmed: 25156013
Cephalalgia. 2016 Oct;36(12):1103-1111
pubmed: 26637237
Neurol Sci. 2022 Nov;43(11):6479-6485
pubmed: 35948778
Nutrients. 2019 Jul 28;11(8):
pubmed: 31357685
BMC Nutr. 2021 Nov 19;7(1):76
pubmed: 34794513
Agri. 2018 Jan;30(1):8-11
pubmed: 29450870